Kingston

Dr. Tu is a Senior Biostatistician/Data Scientist in the Canadian Cancer Trials Group at the Queen’s Cancer Research Institute and an Assistant Professor in the Department of Public Health Sciences. Dr. Tu’s research lies in the intersection of health science and the emerging data science. With the advancement of digital technologies, different sources of data (genetic, imaging, electronic health records, etc.) are available in health science. Trained as a biostatistician, Dr. Tu is interested in integrating these different sources of high-dimensional data and translate into informed clinical decision-making.

Dr. Tu is a Senior Biostatistician/Data Scientist in the Canadian Cancer Trials Group at the Queen’s Cancer Research Institute and an Assistant Professor in the Department of Public Health Sciences. Dr. Tu’s research lies in the intersection of health science and the emerging data science. With the advancement of digital technologies, different sources of data (genetic, imaging, electronic health records, etc.) are available in health science. Trained as a biostatistician, Dr. Tu is interested in integrating these different sources of high-dimensional data and translate into informed clinical decision-making.

Dr. Wendy Parulekar is a graduate of the University of Ottawa where she completed her medical school and specialty training in Internal Medicine and Medical Oncology followed by postgraduate training in clinical pharmacology at the University of Toronto. She currently holds a joint research/clinical position at Queen’s University Cancer Research Institute as a Professor of Oncology and Senior Investigator at the Canadian Cancer Trials Group and Medical Oncologist at the Cancer Centre of Southeastern Ontario. She advises on the clinical trial research agenda for multiple national and international committees including the National Cancer Research Institute (NCRI): International Clinical Trials Awards and Advisory Panel, the European Organization for Research and Treatment of Cancer, Steering Committees for the NCI US, Canadian Institutes of Health Research and the Ontario Institute of Cancer Research.

Dr. Wendy Parulekar is a graduate of the University of Ottawa where she completed her medical school and specialty training in Internal Medicine and Medical Oncology followed by postgraduate training in clinical pharmacology at the University of Toronto. She currently holds a joint research/clinical position at Queen’s University Cancer Research Institute as a Professor of Oncology and Senior Investigator at the Canadian Cancer Trials Group and Medical Oncologist at the Cancer Centre of Southeastern Ontario. She advises on the clinical trial research agenda for multiple national and international committees including the National Cancer Research Institute (NCRI): International Clinical Trials Awards and Advisory Panel, the European Organization for Research and Treatment of Cancer, Steering Committees for the NCI US, Canadian Institutes of Health Research and the Ontario Institute of Cancer Research.